Keyphrases
Diabetes
100%
Nuclear factor-B
100%
RB Pathway
100%
Angiotensin II Type 1 Receptor (AT1R)
100%
Retinal Inflammation
100%
Beta-blockers
54%
Dehydroxymethylepoxyquinomicin (DHMEQ)
36%
Intercellular Adhesion molecule-1 (ICAM-1)
36%
Renin-angiotensin System
27%
AT2R
27%
Protein Level
18%
MRNA Level
18%
Quantitative PCR
18%
Nuclear Translocation
18%
Monocyte Chemoattractant protein-1 (MCP-1)
18%
Angiotensin II (Ang II)
18%
Vascular Endothelial Growth Factor
18%
PD123319
18%
System Components
18%
C57BL
9%
Perfusion
9%
Capillary
9%
High Glucose
9%
Immunohistochemistry
9%
Expression Level
9%
Leukocytes
9%
Labeling Method
9%
Western Blot
9%
Telmisartan
9%
Lectin
9%
Leukocyte Adhesion
9%
Concanavalin A (Con A)
9%
Per Se
9%
Valsartan
9%
Angiotensin II Type 1 Receptor Blocker
9%
In Vivo Applications
9%
Inflammatory Parameters
9%
Retinal Vasculature
9%
Diabetic Retina
9%
Diabetic Retinopathy Treatment
9%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Angiotensin II
100%
Alternative Complement Pathway C3 C5 Convertase
100%
Nuclear Factor
100%
Retinitis
100%
Intercellular Adhesion Molecule 1
50%
Dehydroxymethylepoxyquinomicin
50%
Renin
37%
Angiotensin
37%
Monocyte Chemotactic Protein 1
25%
Vasculotropin
25%
1 (4 Dimethylamino 3 Methylbenzyl) 5 Diphenylacetyl 4,5,6,7 Tetrahydro 1h imidazo[4,5 C]pyridine 6 Carboxylic Acid
25%
Enzyme-Linked Immunosorbent Assay
12%
Western Blot
12%
C57BL 6 Mouse
12%
Telmisartan
12%
Diabetes Mellitus
12%
Concanavalin A
12%
Angiotensin 1 Receptor Antagonist
12%
Lectin
12%
Diabetic Retinopathy
12%
Valsartan
12%